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outpatient encounters, laboratory
results, and pharmacy data). All of
these sources should be evaluated for
completeness and accuracy.
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Concurrent Dengue
and Malaria 
To the Editor: A 37-year-old
woman, a logistics director for a non-
government organization, returned to
France in March 2004 from an 18-day
trip to Guinea, Senegal, and Sierra
Leone. Fever, chills, and myalgia
developed in the woman 3 days before
she returned to France, and she treat-
ed herself with aspirin and paraceta-
mol (acetaminophen). Malaria pro-
phylaxis was taken neither during nor
after the trip. 
The day after returning to France,
the woman’s condition progressively
worsened; diarrhea and extreme
weakness that led to the inability to
walk developed. Ten days after her
return, she was admitted to the local
hospital and treated with intravenous
quinine and oral doxycycline (2 g per
day) after thick and thin blood films
showed 3% parasitemia with
Plasmodium falciparum. Three days
later, she was still febrile and had con-
junctival jaundice, vomiting, insom-
nia, and moderate hemorrhagic mani-
festations (epistaxis, blood in urine
and feces). Three days after initial
hospitalization, the patient was trans-
ferred to the Infectious Diseases Unit
in Marseille; fever (39.5°C) contin-
ued, and hepatosplenomegaly devel-
oped. Biologic analyses showed dis-
seminated intravascular coagulation
with platelet count of 22,000/µL, an
elevated prothrombin time (54%
higher than the control value), a
longer activated clotting time (51 sec-
onds versus a control value of 34 sec-
onds), a fibrinogen level of 0.9 g/dL,
exaggerated plasma fibrin formation
and degradation, and hepatic cytolysis
with both aspartate aminotransferase
and alanine aminotransferase levels of
80 U/L. 
Although acute malaria had been
diagnosed, viral serologic tests were
performed because the patient had
returned from a tropical country with
a fever. Persons in these circum-
stances are systematically adminis-
tered a series of tests to determine the
cause of their fever. Serologic tests for
dengue performed on the acute-phase
serum (collected 13 days after onset
of symptoms) and convalescent-phase
serum (collected 23 days after onset
of symptoms) showed the presence of
immunoglobulin (Ig) M (titers 1:800
and 1:3,200, respectively) and IgG
(titers 1:400 and 1:3,200, respective-
ly), which suggested that the patient
had dengue fever and malaria concur-
rently. These results were obtained by
using the Dengue Duo IgM-capture
and IgG-indirect enzyme-linked
immunosorbent assay (Biotrin,
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The same acute-phase serum was test-
ed for flavivirus RNA by seminested
reverse transcription–polymerase
chain reaction (RT-PCR) by using fla-
vivirus consensus primers PF1S and
PF2R as previously described (1) in
conjunction with the sense primer
PF3S (GCIATHTGGTAYATGTG-
GYT). Attempts to isolate viruses by
using C6/36 and Vero cells were
unsuccessful, which might be expect-
ed given the delay between the onset
of symptoms and specimen collection.
Sequence analysis of the 163-bp
(primers excluded) PCR product
(GenBank accession no. AY862501)
showed 89%–99.4% range of homolo-
gy with 34 dengue 3 virus strains by
using the BLAST nucleotide program.
Similarities obtained with sequences
of dengue virus 1, 2, and 4 were <87%.
Phylogenetic analysis performed with
the patient sequence together with
homologous sequences from dengue
viruses and other flaviviruses showed
that it corresponded to dengue 3 virus
species. RT-PCR amplification on the
convalescent-phase serum was nega-
tive. Based on World Health
Organization criteria, the patient was
diagnosed with dengue fever (2). The
patient’s interview showed a previous
dengue fever episode in Haiti in 1995
and a previous malaria episode in
Burundi in 2002, but biologic confir-
mation was not available, and serum
was not collected before this episode.
Therefore, we could not determine
definitively whether this patient expe-
rienced primary or secondary dengue.
In light of virologic tests results, the
diagnosis of secondary dengue infec-
tion was more likely (3).
A PubMed search using the key-
words dengue, mixed infections, dual
infections, simultaneous infections,
and concurrent infections retrieved 14
references published since 1958. In
most cases, concurrent infection was
with 2 dengue virus strains from 2 dif-
ferent serotypes in a single patient
(4,5). Only 6 published studies report-
ed concurrent infection with dengue
virus and a bacterium (Salmonella
typhi,  Shigella sonnei,  Leptospira
spp.) (6–8) or with a virus such as
Chikungunya virus (9).
To our knowledge, this is the first
report of mixed dengue–parasite
infection, dengue virus with P. falci-
parum. The authors previously ques-
tioned the accuracy of a serologic test
to diagnosis dengue fever in patients
experiencing malaria because reactiv-
ity was nonspecific on certain rapid
serologic assays (10); however, sero-
logic tests used in this study have
demonstrated good specificity (10),
and molecular tests are not prone to
such specificity problems. Classifying
this case as dengue hemorrhagic fever
is questionable since some of the
hemorrhagic signs may have been
caused by acute malaria. In cases of
concurrent infections involving a
dengue virus, questions related to the
influence of mixed infection on sever-
ity and prognosis are, therefore,
impossible to address because of lack
of information. Further investigations
are required because this situation
likely occurs frequently in nature,
despite scant available data.
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West Nile Virus
Detection and
Commercial Assays 
To the Editor: Roehrig and col-
leagues described the long-term per-
sistence of immunoglobulin (Ig) M
antibody in patients with West Nile
virus (WNV) infection, as tested
using an in-house Centers for Disease
Control and Prevention (CDC)
enzyme immunoassay (EIA) (1). This
result suggests that interpreting WNV
IgM results in subsequent years
would be difficult. With the commer-
cial availability and widespread use of
US Food and Drug Administration–